The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway
Kidney International · 2025-08 · 108 (2) · 233-252
DOI: 10.1016/j.kint.2025.04.016 ↗Kurz gefasst
Fachartikel in der Zeitschrift Kidney International, 2025-08. Verfasst von Mingwei Fu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University; Guangdong Provincial Key Laborato…. Hauptthemen laut MEDLINE: Vascular Calcification, NLR Family, Pyrin Domain-Containing 3 Protein, Inflammasomes, DNA-Binding Proteins. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 72 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
INTRODUCTION: Vascular calcification is prevalent in chronic kidney disease (CKD), but existing medical treatments fail to achieve satisfactory therapeutic effects. Vascular calcification is now recognized as an active multifactorial process involving diverse mechanisms. Alpha-ketoglutarate (AKG), an intermediate in tricarboxylic acid cycle, has been demonstrated to extend lifespan and ameliorate age-related osteoporosis. However, whether AKG inhibits vascular calcification remains unknown. METHODS: Here, mineral deposition was studied with AKG treatment in rodent and human vascular smooth muscle cells (VSMCs) under osteogenic conditions in vivo and in vitro. RESULTS: AKG treatment remarkably ameliorated calcification of rat and human arterial rings ex vivo and aortic calcification in CKD rats and mice. Mechanistically, AKG treatment upregulated DNA demethylase ten-eleven translocation 2 (TET2) expression during vascular calcification. Knockdown of TET2 by siRNA and pharmacological inhibition of TET2 by Bobcat339 promoted vascular calcification in rat VSMCs. Bobcat339 also enhanced rat aortic ring calcification. Conversely, TET2 overexpression ameliorated vascular calcification in rat VSMCs, rat aortic rings and CKD rats. Furthermore, VSMC-specific TET2 deficiency promoted aortic calcification in CKD mice. Both TET2 siRNA and Bobcat339 independently counteracted the inhibitory effect of AKG on vascular calcification of rat VSMCs. Inhibitory effect of AKG administration on vascular calcification was reduced in TET2 knockout mice. TET2 overexpression reduced the levels of the NLRP3 inflammasome pathway, cleaved Caspase-1 and IL-1β protein expression in VSMCs and NLRP3 agonist Nigericin-induced cell calcification. CONCLUSIONS: Our study demonstrate that AKG attenuates vascular calcification partially via upregulation of TET2 and inhibition of NLRP3 inflammasome, indicating the critical role of epigenetic modifier in vascular calcification. Modulation of TET2 may become a promising strategy for the treatment of vascular calcification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Laboratory of Heart Center, Heart Center, Zhujiang Hospital, Southern Medical University; Guangdong Provincial Key Laboratory of Cardiac Function and Microcirculation; Guangdong Provincial Biom…
- Department of Anesthesiology, The Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
- Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China.
- Division of Cardiac Surgery, National-Guangdong Joint Engineering Laboratory for Diagnosis and Treatment of Vascular Diseases, NHC Key Laboratory of Assisted Circulation, The First Affiliated Hospital, Sun Yat-Sen Unive…
- Department of Pathophysiology, Zhongshan School of Medicine, Sun Yat-Sen University, Guangzhou, China. Electronic address: lulihe@mail.sysu.edu.cn.
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Fu, M., Lan, Z., Ye, Y., Gong, Y., Liang, Q., Li, M., Feng, L., Chen, A., Dong, Q., Li, Y., Wang, S., Liu, X., Zhang, X., Ou, J. S., Lu, L., & Yan, J. (2025). The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway. Kidney International, 108(2), 233-252. https://doi.org/10.1016/j.kint.2025.04.016
Vancouver
Fu M, Lan Z, Ye Y, Gong Y, Liang Q, Li M, et al. The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway. Kidney International. 2025;108(2):233-252. doi:10.1016/j.kint.2025.04.016
BibTeX
@article{Fu2025,
author = {Fu, Mingwei and Lan, Zirong and Ye, Yuanzhi and Gong, Yuan and Liang, Qingchun and Li, Mingxi and Feng, Liyun and Chen, An and Dong, Qianqian and Li, Yining and Wang, Siyi and Liu, Xiaoyu and Zhang, Xiuli and Ou, Jing-Song and Lu, Lihe and Yan, Jianyun},
title = {The metabolite alpha-ketoglutarate inhibits vascular calcification partially through modulation of the TET2/NLRP3 inflammasome signaling pathway},
journal = {Kidney International},
year = {2025},
volume = {108},
number = {2},
pages = {233--252},
doi = {10.1016/j.kint.2025.04.016}
}
EUVIMED